Company / SG&A per Share
ACCENDRA HEALTH INC/VA/ SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$13.83
FY2025
5-year range
$13.13 / $20.61
FY2021-FY2025
Trend
-2.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $13.13 in FY2023 to $20.61 in FY2022.
Based on SEC 10-K filings.
13.83 in FY2025 with a 5-year CAGR of -3.6%.
Increased from $13.13 to $13.83 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -12.5%
- 5-Year CAGR
- -3.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share decreased 2.2% year-over-year.
- Peak sg&a per share was recorded in FY2022.
- Lowest sg&a per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.60 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.83 | -2.2% |
| FY2024 | $14.14 | +7.7% |
| FY2023 | $13.13 | -36.3% |
| FY2022 | $20.61 | +48.0% |
| FY2021 | $13.92 | -16.0% |
| FY2020 | $16.57 | +6.9% |
| FY2019 | $15.50 | +0.0% |
| FY2018 | $15.50 | -7.0% |
| FY2017 | $16.66 | +7.8% |
| FY2016 | $15.45 | -1.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026